Ondansetron Dosing for a 16-Year-Old with Vomiting
For a 16-year-old weighing 56.6 kg with vomiting, administer ondansetron 8 mg orally (or 0.15 mg/kg IV, which equals approximately 8 mg for this patient) as a single dose, with the option to repeat every 8 hours if vomiting persists. 1, 2
Weight-Based vs. Fixed Dosing
- For adolescents and adults, the standard dose is 8 mg orally or IV, which is appropriate for this 56.6 kg patient 1
- The weight-based dosing of 0.15 mg/kg IV (maximum 16 mg/dose) is equivalent to approximately 8.5 mg for this patient, making the standard 8 mg dose appropriate 1
- For patients 6 months and older, both fixed and weight-based dosing are acceptable, with this adolescent falling well within the adult dosing range 1
Route of Administration Selection
Oral administration is preferred if the patient can tolerate it:
- Oral ondansetron 8 mg (tablet, orally dissolving tablet, or oral soluble film) is the first-line choice for mild-to-moderate vomiting 1
- IV ondansetron 8 mg should be used if the patient has severe vomiting, lethargy, or cannot tolerate oral intake 1
- Orally dissolving tablets are particularly useful for patients with active nausea who may have difficulty swallowing standard tablets 1
Dosing Schedule Based on Severity
For mild vomiting (1-2 episodes, no lethargy):
- Give 8 mg orally as a single dose 1
- Attempt oral rehydration after administration 1
- Can repeat every 8 hours if vomiting recurs, up to maximum 24 mg/day 1
For moderate vomiting (>3 episodes with mild lethargy):
- Administer 8 mg IV or orally 1
- Monitor for 4-6 hours from onset of reaction 1
- Consider IV fluids if oral rehydration fails 1
For severe vomiting (>3 episodes with severe lethargy, hypotension):
- Give 8 mg IV (0.15 mg/kg) immediately 1
- Place IV line for fluid resuscitation with normal saline 20 mL/kg bolus 1
- Consider adding methylprednisolone 1 mg/kg IV (maximum 60-80 mg) for severe cases 1
Multi-Dose Regimens for Ongoing Symptoms
If vomiting persists beyond initial dose:
- Provide 8 mg orally every 8-12 hours for up to 48 hours after initial presentation 2, 3
- Recent high-quality evidence shows that multi-dose ondansetron (up to 6 doses over 48 hours) reduces moderate-to-severe gastroenteritis by 50% compared to placebo (adjusted OR 0.50,95% CI 0.40-0.60) 3
- The total number of vomiting episodes within 48 hours is reduced by approximately 24% with multi-dose therapy 3
Breakthrough Vomiting Management
If ondansetron alone is insufficient:
- Add an agent from a different drug class rather than increasing ondansetron dose 1, 4
- Consider metoclopramide 10-20 mg orally every 6-8 hours as a dopamine antagonist 1
- Alternative: prochlorperazine 5-10 mg orally or IV every 6 hours 1
- For anticipatory nausea, add lorazepam 0.5-2 mg orally every 4-6 hours as needed 1, 2
Important Safety Considerations
QT prolongation concerns:
- The 8 mg dose carries minimal QT prolongation risk compared to the previously used 32 mg IV dose, which is no longer recommended 2
- Standard doses (8 mg) are considered safe for adolescents without significant cardiac risk 4, 2
Common pitfalls to avoid:
- Do not exceed 16 mg as a single IV dose or 24 mg total daily dose in adolescents 1
- Assess for non-vomiting causes (electrolyte abnormalities, increased intracranial pressure) before escalating therapy 2
- Consider adding acid suppression if patient has difficulty distinguishing heartburn from nausea 2